Spanish Pharma Stock News

Aedas Homes (BME:AEDAS) just posted its H1 2026 results, with revenue at €1.2 billion and basic EPS of €3.36 for the trailing twelve months. Looking at recent trends, revenue moved from €914.6 million in H2 2024 to €849.6 million in H2 2025, while EPS has grown from €2.53 to €2.95 over the same periods. Margins held up well, keeping profitability firmly in focus for investors. See our full analysis for Aedas Homes. Next up, we’re stacking these latest numbers against the major narratives...

HBX Group International (BME:HBX) has just released its FY 2025 financial results, revealing second-half revenue of €401 million and net income of €158 million, with basic EPS coming in at €0.64. The company has seen revenue move from €291 million in FY 2024 H1 to €319 million in FY 2025 H1, and then up again to €401 million in FY 2025 H2. Margins moved sharply through the year, highlighting volatile profitability as HBX continues to balance growth expectations with its bottom line...

Wondering if Telefónica stock is a bargain or just another name on your watchlist? Let’s dig into whether now is a smart time to take a closer look at its value. The stock has had its ups and downs recently, rising 3.3% over the past week but still sitting 6.3% lower year-to-date and trailing with an 8.8% loss over the last 12 months. Recent headlines have focused on Telefónica’s ongoing moves in European telecom markets, including fresh partnerships and network upgrades. These developments...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Construcciones y Auxiliar de Ferrocarriles, S.A. ( BME:CAF ), is not the largest company out there, but it saw...

Key Insights Significant control over Meliá Hotels International by private companies implies that the general public...

The board of Mapfre, S.A. ( BME:MAP ) has announced that it will pay a dividend of €0.057 per share on the 28th of...

The European stock market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index falling by 2.21% amid concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut. Despite these challenges, business activity in the eurozone continues to expand steadily, presenting potential opportunities for investors seeking stocks that may be undervalued relative to their intrinsic value. In this context, identifying stocks that are trading...

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have seen a downturn, with major indices like the STOXX Europe 600 Index ending lower. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to navigate these challenging market conditions effectively.

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...

eDreams ODIGEO (BME:EDR) lowered its earnings guidance for 2026 and 2027, citing slower growth in its prime membership base and the effects of a shift toward flexible payment plans for subscribers. See our latest analysis for eDreams ODIGEO. eDreams ODIGEO’s share price has tumbled sharply, down 52% for the month and 59% year-to-date, reflecting fading momentum as investors digest the company’s lower earnings outlook and shifting growth profile. Despite a spike in recent net profit, the...

ACS, Actividades de Construcción y Servicios, S.A.'s ( BME:ACS ) healthy profit numbers didn't contain any surprises...

There's been a major selloff in eDreams ODIGEO S.A. ( BME:EDR ) shares in the week since it released its quarterly...

Enagás, S.A.'s ( BME:ENG ) investors are due to receive a payment of €0.324 per share on 23rd of December. This means...

Grifols (BME:GRF) shares have moved recently, capturing attention after an extended stretch of volatility. Investors are weighing near-term developments as they consider a changing backdrop for the pharmaceutical sector in Europe. See our latest analysis for Grifols. After a turbulent year marked by sharp swings, Grifols’ 8.2% share price return since January stands out, especially as this rise has come despite recent negative momentum, including a 17.3% drop over the last three months and...

eDreams ODIGEO S.A. ( BME:EDR ) shareholders that were waiting for something to happen have been dealt a blow with a...

Shareholders of Solaria Energía y Medio Ambiente, S.A. ( BME:SLR ) will be pleased this week, given that the stock...

ACS, Actividades de Construcción y Servicios, S.A. ( BME:ACS ) last week reported its latest third-quarter results...

Solaria Energía y Medio Ambiente has released its earnings results for the nine months ended September 30, 2025, reporting €258.91 million in revenue and €141.67 million in net income, both sharply higher compared to the previous year. Despite a slight decline in sales, the company achieved a very large year-on-year increase in net income, highlighting a marked improvement in profitability. We'll examine how Solaria's surge in net income, amid higher revenue, affects the company's investment...

Fomento de Construcciones y Contratas, S.A.'s ( BME:FCC ) price-to-earnings (or "P/E") ratio of 27.5x might make it...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Naturgy Energy Group, S.A.'s ( BME:NTGY ) price-to-earnings (or "P/E") ratio of 13.3x might make it look like a buy...

When companies post strong earnings, the stock generally performs well, just like Almirall, S.A.'s ( BME:ALM ) stock...